These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 7751431)

  • 21. Placebo-controlled evaluation of three doses of a controlled-onset, extended-release formulation of verapamil in the treatment of stable angina pectoris.
    Cutler NR; Anders RJ; Jhee SS; Sramek JJ; Awan NA; Bultas J; Lahiri A; Woroszylska M
    Am J Cardiol; 1995 Jun; 75(16):1102-6. PubMed ID: 7762493
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The antianginal effects of a new delayed-release formulation of diltiazem in patients with stable angina pectoris: its evaluation by the ergometry test and dynamic electrocardiogram].
    Metra M; Catalano A; Danesi R; Furloni R; Cuminetti S; Bellandi M; Dei Cas L
    Cardiologia; 1992 Jun; 37(6):403-11. PubMed ID: 1394348
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Conversion from immediate-release to extended-release diltiazem in angina pectoris.
    Pool PE; Thadani U; Miller AB; Fromell GJ; Eff J
    Clin Cardiol; 1994 Sep; 17(9):484-8. PubMed ID: 8001312
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antianginal response to once-daily diltiazem CD in patients receiving concomitant beta-blockers, long-acting nitrates, or both. Diltiazem CD Study Group.
    Heller GV; Sridharan M; Morse J; Glasser S; Beach CL
    Pharmacotherapy; 1997; 17(4):760-6. PubMed ID: 9250554
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of propranolol, diltiazem, and nifedipine in the treatment of ambulatory ischemia in patients with stable angina. Differential effects on ambulatory ischemia, exercise performance, and anginal symptoms. The ASIS Study Group.
    Stone PH; Gibson RS; Glasser SP; DeWood MA; Parker JD; Kawanishi DT; Crawford MH; Messineo FC; Shook TL; Raby K
    Circulation; 1990 Dec; 82(6):1962-72. PubMed ID: 2122926
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diltiazem and propranolol combination for the treatment of chronic stable angina pectoris.
    O'Hara MJ; Khurmi NS; Bowles MJ; Raftery EB
    Clin Cardiol; 1987 Feb; 10(2):115-23. PubMed ID: 3545577
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical experience with a once-daily, extended-release formulation of diltiazem in the treatment of hypertension.
    Graney WF
    Am J Med; 1992 Aug; 93(2A):56S-64S. PubMed ID: 1519637
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparative efficacy and safety of bepridil and diltiazem in chronic stable angina pectoris refractory to diltiazem. The Bepridil Collaborative Study Group.
    Singh BN
    Am J Cardiol; 1991 Aug; 68(4):306-12. PubMed ID: 1858672
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-term efficacy of high-dose diltiazem for chronic stable angina pectoris: 16-month serial studies with placebo controls.
    Petru MA; Crawford MH; Kennedy GT; Amon KW; O'Rourke RA
    Am Heart J; 1985 Jan; 109(1):99-103. PubMed ID: 3880993
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A double-blind comparison of the long-term efficacy of a potassium channel opener and a calcium antagonist in stable angina pectoris.
    Guermonprez JL; Blin P; Peterlongo F
    Eur Heart J; 1993 Jul; 14 Suppl B():30-4. PubMed ID: 8370370
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of morning versus evening dosing of diltiazem on myocardial ischemia detected by ambulatory electrocardiographic monitoring in chronic stable angina pectoris. Dilacor XR Ambulatory Ischemia Study Group.
    Deedwania PC; Pool PE; Thadani U; Eff J
    Am J Cardiol; 1997 Aug; 80(4):421-5. PubMed ID: 9285652
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sustained-release diltiazem versus metoprolol in stable angina pectoris.
    Posma JL; van Dijk RB; Lie KI
    Eur Heart J; 1989 Oct; 10(10):923-7. PubMed ID: 2598950
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy and safety of incremental doses of diltiazem for the treatment of stable angina pectoris.
    Lindenberg BS; Weiner DA; McCabe CH; Cutler SS; Ryan TJ; Klein MD
    J Am Coll Cardiol; 1983 Dec; 2(6):1129-33. PubMed ID: 6355242
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy of metoprolol and diltiazem in treating silent myocardial ischemia.
    Portegies MC; Sijbring P; Göbel EJ; Viersma JW; Lie KI
    Am J Cardiol; 1994 Dec; 74(11):1095-8. PubMed ID: 7977065
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term efficacy of diltiazem controlled release versus metoprolol in patients with stable angina pectoris.
    Vliegen HW; van der Wall EE; Niemeyer MG; Holwerda NJ; Bernink PJ; de Weerd P; Bosma AH; van der Wieken LR; Timmermans AJ; Molhoek GP
    J Cardiovasc Pharmacol; 1991; 18 Suppl 9():S55-60. PubMed ID: 1725545
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Discordance between effects of anti-ischemic therapy on ambulatory ischemia, exercise performance and anginal symptoms in patients with stable angina pectoris. The Angina and Silent Ischemia Study Group (ASIS).
    Borzak S; Fenton T; Glasser SP; Shook TL; MacCallum G; Young PM; Stone PH
    J Am Coll Cardiol; 1993 Jun; 21(7):1605-11. PubMed ID: 8496526
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Double-blind efficacy and safety study of a novel anti-ischemic agent, ranolazine, versus placebo in patients with chronic stable angina pectoris. Ranolazine Study Group.
    Thadani U; Ezekowitz M; Fenney L; Chiang YK
    Circulation; 1994 Aug; 90(2):726-34. PubMed ID: 8044941
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Blood pressure control with diltiazem XR, a novel extended-release formulation of diltiazem HCl, in mature and elderly hypertensive patients.
    Fiddes R; Heym H; Hilty W; Lewin AJ; Codispoti J; McNally C; Stokes A; Gilderman L
    Clin Ther; 1994; 16(2):209-21. PubMed ID: 8062317
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A dose-response study of clentiazem, a chloro-derivative of diltiazem, in patients with stable angina. CAMCAT Study Group.
    Waters D; Garceau D
    J Am Coll Cardiol; 1993 Mar; 21(4):964-70. PubMed ID: 8450166
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antianginal effect of conventional and controlled release diltiazem in stable angina pectoris.
    Boman K; Saetre H; Karlsson LG; Ritter B; Marsell R; Wingman H; Lövheim O; Michaeli EW; Löfdahl P; Olsson SO
    Eur J Clin Pharmacol; 1995; 49(1-2):27-30. PubMed ID: 8751017
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.